Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure

Infliximab is an anti-tumor necrosis factor (TNF) used for treatment of inflammatory bowel disease (IBD) as well as rheumatoid arthritis, psoriasis, and other inflammatory conditions. Antibodies to infliximab (ATI) develop in approximately 45% of infliximab-treated IBD patients and are correlated wi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Ungar, Bella, Haj-Natour, Ola, Kopylov, Uri, Yavzori, Miri, Fudim, Ella, Picard, Orit, Loebstein, Ronen, Lahat, Adi, Maor, Yaakov, Avidan, Benjamin, Lang, Alon, Weiss, Batia, Chowers, Yehuda, Eliakim, Rami, Ben-Horin, Shomron
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2015
Soggetti:
4500
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602524/
https://ncbi.nlm.nih.gov/pubmed/25950682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000673
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi